Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gregory S. Harms
SMADversusNon-SMAD Signaling Is Determined by Lateral Mobility of Bone Morphogenetic Protein (BMP) Receptors
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Ultrastructural Analysis Reveals cAMP-Dependent Enhancement of Microvascular Endothelial Barrier Functions via Rac1-Mediated Reorganization of Intercellular Junctions
American Journal of Pathology
Forensic Medicine
Pathology
Related publications
Bone Morphogenetic Protein-1 (BMP-1)
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
WSS25 Inhibits Growth of Xenografted Hepatocellular Cancer Cells in Nude Mice by Disrupting Angiogenesis via Blocking Bone Morphogenetic Protein (BMP)/Smad/Id1 Signaling
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Regulation of Gastric Lgr5+ve Cell Homeostasis by Bone Morphogenetic Protein (BMP) Signaling and Inflammatory Stimuli
Cellular and Molecular Gastroenterology and Hepatology
Hepatology
Gastroenterology
Involvement of Bone Morphogenetic Protein 4 (BMP-4) in Pituitary Prolactinoma Pathogenesis Through a Smad/Estrogen Receptor Crosstalk
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
High-Throughput Screens for Agonists of Bone Morphogenetic Protein (BMP) Signaling Identify Potent Benzoxazole Compounds
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Mesenchymal Bone Morphogenetic Protein Signaling Is Required for Normal Pancreas Development
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice
Hepatology
Medicine
Hepatology
The Extracellular Regulation of Bone Morphogenetic Protein Signaling
Development (Cambridge)
Developmental Biology
Molecular Biology
Bone Morphogenetic Protein-9 Suppresses Growth of Myeloma Cells by Signaling Through ALK2 but Is Inhibited by Endoglin
Blood Cancer Journal
Oncology
Hematology